NCI Alliance for Nanotechnology in Cancer - from academic research to clinical interventions

被引：7
作者：
Grodzinski, Piotr [1 ]
Liu, Christina H. [1 ]
Hartshorn, Christopher M. [1 ]
Morris, Stephanie A. [2 ]
Russell, Luisa M. [1 ]
机构：
[1] NCI, Nanodelivery Syst & Devices Branch, Canc Imaging Program, Div Canc Treatment & Diag, 9609 Med Ctr Dr, Rockville, MD 20850 USA
[2] NIH, Off Strateg Coordinat, Bethesda, MD 20893 USA
来源：
BIOMEDICAL MICRODEVICES | 2019年 / 21卷 / 02期
关键词：
Cancer nanotechnology; Nanomedicine; multi-disciplinary research; Federal funding; OPPORTUNITIES; CHALLENGES;
D O I：
10.1007/s10544-019-0360-6
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
The National Cancer Institute (NCI) of National Institutes of Health has funded and operated the NCI Alliance for Nanotechnology in Cancer - a large multi-disciplinary program which leverages research at the intersection of molecular biology, oncology, physics, chemistry, and engineering to develop innovative cancer interventions. The program has demonstrated that convergence of several scientific disciplines catalyzes innovation and progress in cancer nanotechnology and advances its clinical translation. This paper takes a look at last thirteen years of the Alliance program operations and delineates its outcomes, successes, and outlook for the future.
引用
收藏
页数：8
相关论文
共 14 条
  • [1] Chapman Sandra, 2012, Nanomedicine (Lond), V7, P321, DOI 10.2217/nnm.12.13
  • [2] Currell F., 2016, CANC NANOTECHNOLOGY, V7
  • [3] NCI investment in nanotechnology: achievements and challenges for the future
    Dickherber, Anthony
    Morris, Stephanie A.
    Grodzinski, Piotr
    [J]. WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2015, 7 (03) : 251 - 265
  • [4] Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
    Farrell, Dorothy
    Ptak, Krzysztof
    Panaro, Nicholas J.
    Grodzinski, Piotr
    [J]. PHARMACEUTICAL RESEARCH, 2011, 28 (02) : 273 - 278
  • [5] Recent Advances from the National Cancer Institute Alliance for Nanotechnology in Cancer
    Farrell, Dorothy
    Alper, Joe
    Ptak, Krzystof
    Panaro, Nicholas J.
    Grodzinski, Piotr
    Barker, Anna D.
    [J]. ACS NANO, 2010, 4 (02) : 589 - 594
  • [6] Cancer nanotechnology: Opportunities and challenges
    Ferrari, M
    [J]. NATURE REVIEWS CANCER, 2005, 5 (03) : 161 - 171
  • [7] Future Opportunities in Cancer Nanotechnology-NCI Strategic Workshop Report
    Grodzinski, Piotr
    Farrell, Dorothy
    [J]. CANCER RESEARCH, 2014, 74 (05) : 1307 - 1310
  • [8] Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
    Hartshorn, Christopher M.
    Bradbury, Michelle S.
    Lanza, Gregory M.
    Nel, Andre E.
    Rao, Jianghong
    Wang, Andrew Z.
    Wiesner, Ulrich B.
    Yang, Lily
    Grodzinski, Piotr
    [J]. ACS NANO, 2018, 12 (01) : 24 - 43
  • [9] Relative Citation Ratio (RCR): A New Metric That Uses Citation Rates to Measure Influence at the Article Level
    Hutchins, B. Ian
    Yuan, Xin
    Anderson, James M.
    Santangelo, George M.
    [J]. PLOS BIOLOGY, 2016, 14 (09)
  • [10] Lenoir T, 2015, J NANOMEDINE BIOTHER, V5, P2
12